Molecular Formula | C19H27N5O5 |
Molar Mass | 405.45 |
Melting Point | 117.5-118.5°; mp 125-126° (Katakami, 1992) |
Boling Point | 597.9°C at 760 mmHg |
Flash Point | 315.4°C |
Vapor Presure | 3.84E-15mmHg at 25°C |
overview | nifikalan (nifekalant) is a simple potassium channel Ikr blocker, which not only has an effect on ventricular arrhythmia, but also has a good therapeutic effect on drugs for supraventricular arrhythmias such as atrial fibrillation and atrial flutter. |
use | nifekalan (nifekalant) is a simple potassium channel Ikr blocker, a newly developed class III antiarrhythmic drug, which can be used to treat the following symptoms of arrhythmia: ventricular tachycardia and ventricular fibrillation; It has a high inhibitory effect on severe ventricular arrhythmia. |